
|Podcasts|December 23, 2020
Comparing micro-bypass implant + phaco vs phaco in POAG
Author(s)David Hutton, Alex Delaney-Gesing
Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.
Advertisement
During AAO 2020, Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
How AI is reshaping ophthalmology in 2025 and beyond
2
Glaucoma 2026: Which emerging technologies will change practice?
3
Molecular insights and clinical experience: Extending anti-VEGF durability
4
8 things to know about aflibercept 8 mg for retinal vascular disease
5












































